Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2024 Debates and Didactics in Hematology and Oncology
European Association for the Study of Diabetes Annual Meeting 2024
2024 ASCO Breakthrough
2024 Pan Pacific Lymphoma Conference
European Hematology Association 2024 Congress
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Conquer Cancer Foundation
November 10, 2018
Advertisement
Advertisement
Advertisement
Sep
08
Today In Oncology
FDA Approves Ready-to-Use Version of Bortezomib for Subcutaneous Administration
Omitting 5-FU Bolus May Reduce Side Effects in Patients With Gastrointestinal Cancers
How Accurate Is Staging in Early Pancreatic Cancer
Study Supports Universal Genetic Testing of Newly Diagnosed Patients With Invasive Breast Cancer
Prostate Cancer Mortality and 5-ARI Use
View More
Advertisement
